Device Compatibility &
Product Partner Programme.
Supporting safe, evidence led UV-C decontamination pathways for reusable medical devices.
Mackwell Health works with healthcare providers, clinical teams and medical device manufacturers to support the evaluation of device specific UV-C decontamination pathways. Our approach considers not only microbial reduction, but also device materials, geometry, decontamination preconditions, traceability, manufacturer guidance and practical adoption in real healthcare settings.
Reuse depends on confidence in the pathway.
Reusable medical devices can reduce waste and long-term cost, but adoption depends on confidence that the decontamination pathway is effective, repeatable, traceable and does not compromise device performance or integrity. Healthcare teams need clear work instructions, infection prevention review and device specific evidence before introducing a new process into clinical use.
Clinical confidence
Supporting infection prevention and clinical teams with structured evaluation, workflow review and evidence led deployment - so a new process can be introduced with care.
Device integrity
Considering materials, optics, screens, buttons, seals, handles, connectors and repeat cycle exposure, so decontamination does not compromise device performance.
Reusable healthcare
Helping healthcare organisations reduce avoidable single use waste through practical, repeatable reusable device pathways that hold up in real clinical settings.
A structured, device by device review.
A collaborative process, led with the manufacturer from the very first step. Every device is different and standards vary by market - from early engagement through testing, independent verification and documentation.
Open a collaborative dialogue with the manufacturer from the very start. They own the device's Instructions for Use (IFU), so we work in partnership from day one.
Together, assess the device, clinical setting, existing decontamination process, materials, constraints and the manufacturer's Instructions for Use (IFU).
Review geometry, shadowing risk, exposed surfaces, cycle parameters and pre-decontamination requirements.
Carry out extensive UV-C testing in our own laboratories and, where necessary and on an agreed basis, independent third party testing to BS8628:2022 and the standards agreed for each market - working, where supported, toward possible inclusion in the device's IFU.
A staged model - without implying approval too early.
Manufacturer agreement is sought at each stage - agreeing criteria and the applicable standards for each market, through to a process that may, where formally agreed, be included in the device's Instructions for Use (IFU). Each stage keeps every claim accurate to where a pathway actually is.
A reusable device category identified as potentially suitable, with early manufacturer dialogue and assessment of materials, geometry and decontamination requirements.
Agree acceptance criteria and a practical global standards roadmap with the manufacturer, since criteria and standards vary by market.
Extensive UV-C testing carried out on the device in Mackwell's own laboratories, against the agreed acceptance criteria and thresholds.
Independent third party laboratory testing to BS8628:2022 and the equivalent standards agreed for each market, on the agreed criteria.
Evaluation with healthcare stakeholders for workflow, usability and traceability, alongside device specific process documentation.
Where testing supports it and the manufacturer agrees in writing, the process may be included in the device's Instructions for Use (IFU). Used only where formal approval has been received.
Status descriptions are for pathway management and do not imply endorsement, approval, validation or procurement commitment unless expressly stated.
Example categories under review.
These are illustrative reusable device categories of interest. Specific brands and models are not listed unless a manufacturer has agreed to be named.
Built around the devices your teams rely on every day.
Two routes into the programme.
Public & private healthcare teams
Mackwell Health supports public and private healthcare teams worldwide seeking to evaluate reusable device pathways through structured workflow review, training, traceability, service evaluation and sustainability data capture. The objective is to help teams assess whether UV-C-enabled decontamination can be adopted safely and practically within their local governance requirements.
Manufacturers
Mackwell Health works with manufacturers to explore device specific compatibility, documentation requirements and potential pathway approval. The aim is to support responsible adoption of reusable medical devices without compromising device integrity, performance or manufacturer guidance.
Collaboration is not endorsement.
Mackwell Health does not present clinical collaboration, manufacturer engagement or product compatibility review as endorsement. Public references to healthcare organisations, clinicians, manufacturers, product names, logos, approval status or evaluation outcomes are only made where appropriate permission has been granted and wording has been agreed.
A scientific foundation, applied with care.
UV-C is a well established disinfection technology, with published evidence demonstrating effective microbial inactivation under defined conditions. Mackwell Health applies this scientific foundation to practical healthcare workflows, focusing on repeatability, traceability, device suitability, clinical usability and safe adoption.
Performance is always pathway specific. Device specific validation is required before any pathway is adopted, and any efficacy figures are only published where they are linked to validated, device specific test data and approved wording.
Interested in evaluating a reusable device pathway?
If you are a healthcare provider, clinical team or medical device manufacturer interested in assessing UV-C-enabled decontamination compatibility, Mackwell Health can support a structured review.
We respond to all enquiries and will suggest a device specific review where appropriate. Nothing is shared publicly without written agreement.